Upload
asri
View
236
Download
0
Embed Size (px)
Citation preview
8/17/2019 ltm 4 asri ginjal.pptx
1/12
Tatalaksana FarmakologisBPH & OAB
Asri Salima Ridw14065452
8/17/2019 ltm 4 asri ginjal.pptx
2/12
OVRA!T"V B#A$$R %OA
• orang 'ang s()(ntar2
k( w*+ tidak )isa ta,an
-i-is %)(s(r
• $iagnosis m.da,
• laki2/ dari a.,
t(r*i.m)a. -(sing
OAB
• Turunan/ dari(na*in+ soli(n
• MA/ antagonis r(s(-tor 3
%mikturisi) -ada md(tr.sor
).in t,( )ladd(r
• Efek samping/ anti*,olin(rg
%mulut dan kulit kering karena
produksi ludah berkurang
• Kontraindikasi/ arrowang
gla.*oma+ .rinar' r(t(ntion+gastro-ar(sis+ gastri* o)str.*
8/17/2019 ltm 4 asri ginjal.pptx
3/12
B"7 PROSTAT H8PRP#A%BP
• Turunan/ P,(no9')(n:amin(+ Pra:osin+ t(ra:osin+ do9a:%)ikin ,i-(rt(nsi+ tams.losin %r(lati aman+ ;000
8/17/2019 ltm 4 asri ginjal.pptx
4/12
8/17/2019 ltm 4 asri ginjal.pptx
5/12
$osis
8/17/2019 ltm 4 asri ginjal.pptx
6/12
(k Sam-i
• Efek samping/
• ort,ostati* ,i-ot(nsi %-(n.r.nant(kanan dara, %20 sistol+ 10 diasaat )(rdiri dari -osisi d.d.k ata
tid.ran• P.sing
• asal *ong(stion %-(m)(ngakakk-(m).l., dara, s.m)atan
• Pal-itasi %,ard )(ats+ ast )(ats+
irr(g.lar ,(art )(at
8/17/2019 ltm 4 asri ginjal.pptx
7/12
A7TS FOR B"7 PROSTAH8PRP#AS"A %BPH
5 - reductase
inhibitor
• Turunan/ =nast(rid( %ti-( 2+
d.tast(rid( %ti-( 1+ 2
• MA/ m(n*(ga, @0? 5
r(d.*tas( %katalase testosteron
dihydrotestosterone (DHT s,gm(ng,am)at -(rt.m).,an
8/17/2019 ltm 4 asri ginjal.pptx
8/12
Tipe 1
di k.lit dan s*al- d(wasa
%,air ormation
-rostat( *an*(r %in*r(as(d
l(>(ls o mRA (9-r(ssion+
-rot(in+ and .n*tional
(n:'m(s ,a>( )((n
d(monstrat(d in -rostat(
*an*(r
Tipe BPH
8/17/2019 ltm 4 asri ginjal.pptx
9/12
Farmakokinetik /
Absorpsi/ a)sor)si di .s.s ,al.s+ -(ak tim(/ 12 am+
)ioa>aila)ilitas ;0?
Distribusi/ m(n(m).s BBB+ -lasma -rot(in )inding/ @0?
Metabolime/ Hati ol(, iso(n:im !8P3A4
Ekskresi/ (s(s %5?+ .rin %3@?
• Efek samping/
• t(stost(ron )(rk.rang li)ido )(rk.rang dis.ngsi s(9.a
• risiko *a*at )a'i ika Anda m(ng,amili -(r(m-.an saat s(da
m(nalani -(ngo)atan d(ngan k(d.a o)at ini
8/17/2019 ltm 4 asri ginjal.pptx
10/12
8/17/2019 ltm 4 asri ginjal.pptx
11/12
CS"PD#A
Al-,a)lo*k(rs+ s(-(rti t(ra:osin m(ringankan g(ala BPH dalam )()(r
mingg.+ t(ta-i tidak m(ng,(ntikan -ros(s -(m)(saran -rostat6+
5al-,a r(d.*tas( in,i)itors+ d.tast(rid( ata. =nast(rid( da-at m(ng.
-(m)(saran -rostat t(ta-i m(m).t.,kan 6 ).lan ata. l()i, .nt.k
m(n.n.kkan ((k -ada g(ala 6+
P,os-,odi(st(ras(5 %P$5 in,i)itor+ s(-(rti tadala=l da-at m(m)ant
m(ng.rangi g(ala BPH a-a)ila m(miliki masala, (r(ksi P$5 in,i)ito
dik(nal o)at .nt.k (r(ksi 6+
Eadi+ k(sim-.lann'a adala, a-a)ila s(sorang t(rk(na -(n'akit BPH+ )(
kom)inasi dari al-,a)lo*k(r d(ngan angka -anang dan 5al-,a r(d.
in,i)itor kar(na k(d.an a m(m .n ai .n si an )(r)(da dan )(k(r
8/17/2019 ltm 4 asri ginjal.pptx
12/12
R((r(n1 Fink(l R+ ,al(n C+ Fink(l R+ Pana>(lli T #i--in*ott "ll.strat(d R(>i(ws/ P,arma*olog' 6 t, (d
P,ilad(l-,ia/ olt(rs Cl.w(rG 2015
2 Cat:.ng B7 Basi* and !lini*al P,arma*olog' 10t, (d San Fransis*o/ * 7raw HillG 2006
3 *Anin*, + #.( T Smit, & Tanag,os 7(n(ral Drolog' 1;t, (d !aliornia/ *7raw Hill (di*al
-2011;
4 Br.nton #+ #aso E+ (t al 7oodman & 7ilmans T,( P,arma*ologi*al Basis o THRAPDT"!S 11t
!aliornia/ *7raw HillG 2006 -2102;
5 S(tia).d' R Anti)ioti*s and Antis(-ti*s or Drinar' Tra*t "n(*tions Eakarta/ $(-art(m(n FarmaFCD" Ik.lia,J Idi)(rikan -ada/ S(lasa+ 16 F()r.ari 2016J
6 Ro(,r)orn !7 T,( (K(*ts o d.tast(rid(+ tams.losin and *om)ination t,(ra-' on low(r .rinars'm-toms in m(n wit, )(nign -rostati* ,'-(r-lasia and -rostati* (nlarg(m(nt/ 2'(ar r(s.lts
t,( !om)AT st.d' Eo.rnal o Drolog'+ 1@%2/ 616621 200; %a**(ss(d F() 2 2016 A>aila)l(
,tt-/